Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Phylos

Explore full profile

Phylos is dedicated to the discovery and development of novel biopharmaceuticals

Lexington, United StatesBiotech & Life Sciences
Valuation $100–250M Last recorded · 2001
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Phylos and the history behind them.

About Phylos

Phylos operates as an agricultural genomics company with a sharp focus on the cannabis sector, founded in February 2014 by Mowgli Holmes and Nishan Karassik in Portland, Oregon. Holmes, an evolutionary biologist, identified a significant lack of scientific research in the cannabis industry as it was beginning to expand. This observation prompted the creation of Phylos to apply modern science to cannabis cultivation. Karassik brought entrepreneurial experience to the venture. The company initially gained prominence by developing the Phylos Galaxy, a 3D interactive map visualizing the genetic relationships between thousands of cannabis varieties, created in partnership with the American Museum of Natural History.

The firm's business model is centered on empowering cannabis growers by providing genetically superior products and data. It generates revenue through the sale of its proprietary cannabis seeds to both commercial-scale cultivators and home growers, offering volume pricing for larger clients. Phylos has also established the "Natural Natural" brand to market products containing rare cannabinoids like THCV, which it derives from its specialized plant varieties. A key part of its strategy involves forming innovation partnerships with operators, such as Organigram in Canada, providing them with genetic material and expertise to improve cultivation efficiency and develop new products.

Phylos' core offering is its Production-Ready Seed™, which includes fully feminized, F1 hybrid seed lines. These seeds are designed to produce plants with high uniformity, vigor, and desirable traits like specific cannabinoid and terpene profiles, rivaling the consistency of traditional cloning methods. The benefits for growers include reduced operational costs, elimination of mother rooms, shorter cultivation cycles, and decreased risk of pests and diseases like Hop Latent Viroid (HLVd). The company offers several seed categories, including Elite, Premium, and Autoflower varieties, catering to different grower needs and expertise levels. The development process utilizes marker-assisted selection, allowing Phylos to identify desirable traits at the seedling stage and accelerate breeding cycles.

Source: Dealroom company data

At a glance

Status
Operational
Headquarters
Lexington, United States
Open positions
None listed
Dealroom signal
1.4/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Jan 2001 $25M $100M Lone Pine Capital · Sprout Group · Three Arch Partners —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Phylos website traffic

Latest recorded traffic for Phylos is 0 monthly website visits, down 100% over the last three months.

Latest monthly visits0 3-month web change-100%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Lone Pine Capital
  • Sprout Group
  • Three Arch Partners
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Lexington HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Phylos on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Phylos’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.